4//SEC Filing
Korbel Gregory Alan 4
Accession 0001104659-22-033392
CIK 0001781983other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:03 PM ET
Size
9.1 KB
Accession
0001104659-22-033392
Insider Transaction Report
Form 4
Korbel Gregory Alan
VP of Business Dev't
Transactions
- Award
Common Stock
2022-03-10+16,000→ 31,841 total - Tax Payment
Common Stock
2022-03-10$1.82/sh−1,989$3,620→ 29,852 total - Award
Stock Option (right to Buy)
2022-03-10+72,600→ 72,600 totalExercise: $1.82Exp: 2032-03-10→ Common Stock (72,600 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units which were granted on March 10, 2022, and which will vest and be settled in common stock as follows: (i) 5,333 shares on March 10, 2023, (ii) 5,333 shares on March 10, 2024 and (iii) 5,334 shares on March 10, 2025, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 5,000 restricted stock units
- [F3]Twenty-five percent of these options vest on March 10, 2023, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001789032
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:03 PM ET
- Size
- 9.1 KB